AI GxP validation for regulated life sciences
GxP AI

How to Qualify an AI Vendor for GxP Use

Supplier qualification for AI vendors differs from conventional software. What to ask, what evidence to demand, how to assess a model you cannot inspect, and the contract terms that protect you later.

Cybroscape Technologies8 min read

Key takeaway

Supplier qualification for AI vendors differs from conventional software. What to ask, what evidence to demand, how to assess a model you cannot inspect, and the contract terms that protect you later.

Supplier qualification was designed for software that behaves the same way every time you run it. AI does not necessarily do that, and the standard questionnaire does not ask about the things that matter. A vendor can answer every question on your existing form truthfully and still leave you unable to defend the system in an inspection.

This guide covers what to ask an AI vendor, what evidence to demand rather than accept on assertion, how to assess a model you cannot inspect directly, and the contract terms that determine whether you can keep operating when something changes. It assumes the general context set out in GxP AI.

What the standard questionnaire misses

A conventional supplier assessment asks about the vendor's quality system, development lifecycle, testing practice, change control and security. All still necessary. None of it addresses the four questions specific to AI:

  • Does the system's behaviour change without a release? If the underlying model can be updated by the vendor or a third party without a versioned, notified change, your validated state has an expiry date you do not control.
  • Is the output reproducible? Can the vendor demonstrate that the same input produces the same output, and if not, what is the bounded variation? "Approximately the same" is not a validation acceptance criterion.
  • Where does the reasoning come from? Can a reviewer see why the system produced this output — the source passages, the rule applied, the confidence — or only the output itself?
  • What happens to your data? Processing boundary, retention, and whether your content is used to improve the vendor's models. Covered in depth in data privacy in GxP AI.

The questions to ask, and what a good answer sounds like

On change control

"If the model behind this feature is updated, how am I notified and what are my options?"

A good answer describes versioning, advance notice with a defined period, release notes that state what changed in behavioural terms, and the ability to remain on a prior version for a stated window while you reassess. A weak answer is "we continuously improve the model" — which means your validated state can change silently, and no validation package survives that.

On reproducibility

"Show me the same input run ten times."

Ask for this in the evaluation, with your own documents. Some variation in phrasing may be acceptable for a drafting task where a human approves the result. Variation in a classification, a risk score or a pass/fail determination is a different matter. Establish which of your use cases tolerate variance and which do not, then test exactly those.

On evidence and traceability

"For a given output, what can a reviewer see about how it was produced?"

You want citation to source, a record of the inputs used, the version of the system that produced it, a timestamp, and the identity of the person who reviewed it — all captured in a tamper-evident audit trail. If the vendor can only show you the answer, your reviewer cannot perform a meaningful check and your human oversight is ceremonial.

On performance claims

"What is the measured accuracy, on what data, and how was it measured?"

A credible answer names an evaluation set, describes how ground truth was established, and reports failure modes as well as success rates. A vendor who cannot tell you how their system fails has not characterised it. Marketing accuracy figures with no stated methodology should be treated as unsupported — the pattern examined in AI washing.

On the regulatory position

"Which specific requirements does your evidence address, and which remain mine?"

The right answer is a clear division, not a claim of total coverage. A vendor asserting their product is "fully compliant" and needs no validation is describing something that cannot exist — compliance depends on your configuration, your data and your process.

Assessing a model you cannot inspect

You will usually not be given model weights or architecture, and demanding them is rarely productive. You do not need them. What you need is behavioural evidence, and that you can generate yourself.

  • Test with your own material. Vendor demos use curated inputs. Bring your genuinely messy documents — the badly scanned one, the one with an inconsistent template, the one written by someone who left. Performance on those is the performance you will get.
  • Test the failure path deliberately. Give it something outside its competence and observe whether it declines, flags low confidence, or answers confidently and wrongly. The third behaviour is the dangerous one and it is the one to probe for.
  • Test the review experience, not just the output. Time how long it takes a qualified reviewer to verify a generated document against source. If verification takes as long as authoring, the efficiency case does not hold regardless of output quality.
  • Test at your data boundary. Documents containing product names, patient identifiers or commercially sensitive material — confirm the handling matches the contract before, not after, you sign it.

This behavioural approach is what AI validation services formalise, and it is the same evidence base your eventual validation package draws on.

Contract terms that matter later

  • Notice period for model changes, with a right to remain on the prior version for a defined window.
  • An explicit statement that your data is not used for model training, if that is your requirement — and it usually is. Silence is not a commitment.
  • Audit rights. The right to audit the vendor, or to receive a recent independent audit report, in a form your QA will accept.
  • Data export in a usable, documented format. Your records must outlive the relationship, and retention obligations are long — see GxP archiving and data retention.
  • Subprocessor disclosure and notification. If your content is processed by a party the vendor contracts with, you need to know who and where.
  • Incident notification within a defined period, covering security events and material defects affecting output correctness.

The qualification decision is ultimately about whether you can defend the system without the vendor in the room. If every answer to an inspector's question begins "we would need to ask the supplier", the qualification has not done its job. What inspectors ask about AI is a useful test to run against any vendor before signing.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

Part of our guide to GxP AI — the regulatory framework, validation expectations and platform landscape.

AI drafts
AI-drafted
Source linked
Your reviewerApprove and signSend back with comments
Signed record
  • Signer’s name
  • Date and time
  • Meaning of the signature
  • Entry in the audit trail
The AI never approves its own work
Where the AI stops: it drafts and links each statement to its source. A qualified person reviews, edits and signs. Only the signed version becomes the record.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.
ai vendor qualificationgxp ai supplier auditqualify ai vendor pharmaai supplier assessment gxpai vendor due diligencesoftware supplier qualification ai
FAQ

Frequently Asked Questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

How is qualifying an AI vendor different from normal supplier qualification?

A standard questionnaire covers the vendor's quality system, development lifecycle, testing and security — all still necessary but none of it AI-specific. Four additional questions matter: whether system behaviour can change without a release, whether output is reproducible, whether a reviewer can see the reasoning behind an output, and what happens to your data. A vendor can answer a conventional form truthfully and still leave you unable to defend the system.

What should you ask an AI vendor about model updates?

Ask how you are notified if the underlying model changes and what your options are. A good answer describes versioning, advance notice over a defined period, release notes stating what changed behaviourally, and the ability to stay on a prior version while you reassess. 'We continuously improve the model' means your validated state can change silently, and no validation package survives that.

How do you assess an AI model you cannot inspect?

With behavioural evidence you generate yourself, not model internals. Test with your own messy documents rather than the vendor's curated demo set. Test the failure path deliberately to see whether it declines, flags low confidence, or answers confidently and wrongly. Time how long a qualified reviewer takes to verify output — if verification takes as long as authoring, the efficiency case fails.

What contract terms matter when buying GxP AI software?

A notice period for model changes with the right to remain on a prior version; an explicit written statement that your data is not used for model training; audit rights or an acceptable independent audit report; data export in a usable documented format, since retention obligations are long; subprocessor disclosure and change notification; and incident notification within a defined period covering both security events and defects affecting output correctness.

Can a vendor say their AI product needs no validation?

They can say it, but it cannot be true. Compliance depends on your configuration, your data and your process, none of which the vendor controls. The right answer to 'which requirements does your evidence address' is a clear division between what the supplier covers and what remains yours — not a claim of total coverage.

Keep reading

All articles
SupplierAnnex 11 Chapter 7 already covers your AI vendorYour AI supplier obligations are not waiting for Annex 22. EMA's workshop report records that Chapter 7 is fully applicable because AI systems are computerised systems. · 8 min readGxP AIUpdating SOPs and Training When You Introduce AIIntroducing AI changes who does what, which means your SOPs and training records must change too. Which procedures need revision, what the new competency looks like, and how to document oversight so it is real. · 8 min readGxP AIContinuous Monitoring for AI in GxP: Why One-and-Done Validation FailsAI validation in GxP cannot follow the traditional CSV model. Here is the continuous validation framework: model drift detection, performance monitoring, periodic re-qualification, and Annex 22 assurance. · 6 min readGxP AIWhat Is GxP AI? AI in Regulated Life Sciences, ExplainedGxP AI is AI used in GMP, GCP, GLP, GDP or GVP work. What makes it harder to validate than ordinary software, what FDA, the draft EU Annex 22 and GAMP actually say, and how to start. · 6 min readGxP AIClassifying AI Use Cases by Risk: From Tier to Regulatory ComplianceThe complete GxP AI framework: risk-based classification of AI use cases, GAMP 5 category mapping, regulatory expectations (FDA, EMA, MHRA), and the compliance architecture that holds under inspection. · 5 min readGxP AICSA vs CSV for AI Systems: Which Validation Approach Works for GxP AI and Why It MattersThe Computer Software Assurance vs Computer System Validation debate applied specifically to AI/ML systems: where CSA reduces burden, where CSV still applies, and how to document the decision defensibly. · 6 min readGxP AIExplainable AI in GxP Validation: Why Black-Box Models Fail Inspection and What to Use InsteadWhy GxP regulators reject black-box AI, what explainability actually means in a validated environment, and the architectural patterns that make AI decisions auditable and defensible. · 6 min readGxP AIFDA vs EMA vs MHRA: What Each Regulator Actually Says About AI in GxP (2026 Update)A side-by-side comparison of what FDA, EMA, and MHRA have published on AI in GxP environments: guidance documents, draft frameworks, and the practical compliance differences that matter for global programmes. · 7 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.